Identification and characterization of novel B-cell epitopes within EBV latent membrane protein 2 (LMP2)

Viral Immunology

Volumn 24, Issue 3, 2011, Pages 227-236

  Xue, Xiangyang ^a   Zhu, Shanli ^a   Li, Wenshu ^a   Chen, Jun ^a   Ou, Qin ^a   Zheng, Meixia ^a   Gong, Wenci ^a   Zhang, Lifang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLISOLEUCYLGLUTAMYLASPARTYLPROLYLPROLYLPHENYLALANYLASPARAGINYLSERYLLEUCYLLEUCINE; HYBRID PROTEIN; LATENT MEMBRANE PROTEIN 2; LYSYLSERYLLEUCYLSERYLSERYLTHREONYLGLUTAMYLPHENYLALANYLISOLEUCYLPROLYLASPARAGINE; THREONYLLEUCYLASPARAGINYLLEUCYLTHREONINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BIOINFORMATICS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; FEMALE; HUMAN; HYDROPHILICITY; IMMUNE SYSTEM; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SURFACE PROPERTY;

ADULT; AGED; ANIMALS; ANTIBODIES, VIRAL; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; EPSTEIN-BARR VIRUS INFECTIONS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNODOMINANT EPITOPES; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROTEIN STRUCTURE, SECONDARY; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; MUS;

EID: 79959306382     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2010.0092     Document Type: Article

References (31)

1. Allen MD, Young LS, and Dawson CW: The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J Virol 2005;79:1789-1802. (Pubitemid 40459124)
2. Beaufils P, Choquet D, Mamoun RZ, and Malissen B: The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J 1993;12:5105-5112. (Pubitemid 23358500)
3. Chen Y, Yao K, Sun H, Qing J, and Peng GY: Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies. Chin Med J (Engl) 2005;118:725-730. (Pubitemid 40674362)
4. Emini EA, Hughes JV, Perlow DS, and Boger J: Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 1985;55:836-839. (Pubitemid 16254565)
5. Farwell DG, McDougall JK, and Coltrera MD: Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion. Ann Otol Rhinol Laryngol 1999;108:851-859. (Pubitemid 29461197)
6. Fruehling S, Lee SK, Herrold R, Frech B, Laux G, Kremmer E, Grasser FA, and Longnecker R: Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J Virol 1996;70:6216-6226. (Pubitemid 26266840)
7. Garnier J, Gibrat JF, and Robson B: GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol 1996;266:540-553.
8. Geourjon C, and Deleage G: SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 1995;11:681-684. (Pubitemid 26032758)
9. Herr W, Ranieri E, Gambotto A, Kierstead LS, Amoscato AA, Gesualdo L, and Storkus WJ: Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood. Proc Natl Acad Sci USA 1999;96:12033-12038. (Pubitemid 29502853)
10. Hirokawa T, Boon-Chieng S, and Mitaku S: SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998;14:378-379. (Pubitemid 28393805)
11. Hopp TP, and Woods KR: Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981;78:3824-3828. (Pubitemid 11060471)
12. Jameson BA, and Wolf H: The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 1988;4:181-186. (Pubitemid 18072035)
13. Kanaya S, Yamada Y, Kinouchi M, Kudo Y, and Ikemura T: Codon usage and tRNA genes in eukaryotes: correlation of codon usage diversity with translation efficiency and with CG-dinucleotide usage as assessed by multivariate analysis. J Mol Evol 2001;53:290-298. (Pubitemid 32889537)
14. Khanna R, Burrows SR, Silins SL, Moss DJ, Poulsen LM, and Burrows JM: Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants. J Virol 1996;70:7306-7311. (Pubitemid 26307458)
15. Kolaskar AS, and Tongaonkar PC: A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990;276:172-174.
16. Kuzushima K, Hayashi N, Kudoh A, Akatsuka Y, Tsujimura K, Morishima Y, and Tsurumi T: Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells. Blood 2003;101:1460-1468. (Pubitemid 36182521)
17. Lalonde A, Avila-Carino J, Caruso M, and de Campos-Lima PO: Rescue of the immunotherapeutic potential of a novel T cell epitope in the Epstein-Barr virus latent membrane protein 2. Virology 2007;361:253-262. (Pubitemid 46574842)
18. Lautscham G, Haigh T, Mayrhofer S, et al.: Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2. J Virol 2003;77:2757-2761. (Pubitemid 36222802)
19. Lee SP, Chan AT, Cheung ST, et al.: CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. J Immunol 2000;165:573-582. (Pubitemid 30429553)
20. Lee SP, Tierney RJ, Thomas WA, Brooks JM, and Rickinson AB: Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J. Immunol 1997;158:3325-3334. (Pubitemid 127484050)
21. Leen A, Meij P, Redchenko I, Middeldorp J, Bloemena E, Rickinson A, and Blake N: Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses. J Virol 2001;75:8649-8659. (Pubitemid 32768969)
22. Lennette ET, Winberg G, Yadav M, Enblad G, and Klein G: Antibodies to LMP2A/2B in EBV-carrying malignancies. Eur J Cancer 1995;31A:1875-1878.
23. Longnecker R: Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv Cancer Res 2000;79:175-200.
24. Lynch DT, Zimmerman JS, and Rowe DT: Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells. J Gen Virol 2002;83:1025-1035. (Pubitemid 34477274)
25. Niedobitek G: Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 2000;53:248-254.
26. Pang MF, Lin KW, and Peh SC: The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Cell Mol Biol Lett 2009;14:222-247.
27. Shah KM, and Young LS: Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect 2009;15:982-988.
28. Straathof KC, Leen AM, Buza EL, et al.: Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma. J Immunol 2005;175:4137-4147. (Pubitemid 41292078)
29. Sung NS, Edwards RH, Seillier-Moiseiwitsch F, Perkins AG, Zeng Y, and Raab-Traub N: Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int J Cancer 1998;76:207-215. (Pubitemid 28180374)
30. Wang B, Yao K, Liu G, Xie F, Zhou F, and Chen Y: Computational prediction and identification of Epstein-Barr virus latent membrane protein 2A antigen-specific CD8+ T-cell epitopes. Cell Mol Immunol 2009;6:97-103.
31. Zimmerman JM, Eliezer N, and Simha R: The characterization of amino acid sequences in proteins by statistical methods. J Theor Biol 1968;21:170-201.